Mid-Year Report

FOLEY HOAG LLP for ELI LILLY AND COMPANY

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Follow-on biologics -- S 1695 FDA Reform bills -- S 1082, HR 2900

LobbyistCovered position, as disclosed
PAUL KIM N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2900 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.